Copyright
©The Author(s) 2016.
World J Gastroenterol. Mar 7, 2016; 22(9): 2844-2854
Published online Mar 7, 2016. doi: 10.3748/wjg.v22.i9.2844
Published online Mar 7, 2016. doi: 10.3748/wjg.v22.i9.2844
Table 3 Unadjusted logistic regression analysis of factors associated with hepatic decompensation/serious adverse events
Unadjusted | |||
OR | 95%CI | P value | |
Demographics and clinical characteristics | |||
Age (yr) | 1.00 | 0.92-1.09 | 0.97 |
Gender, female | 2.13 | 0.47-9.72 | 0.40 |
Race, black | 0.73 | 0.01-9.98 | 1.00 |
Ethnicity, Hispanic | 0.22 | 0.01-2.07 | 0.30 |
Weight (lbs) | 0.98 | 0.95-1.00 | 0.06 |
BMI (kg/m2) | 0.87 | 0.73-1.04 | 0.13 |
Years since transplant | 0.96 | 0.83-1.10 | 0.52 |
Comorbidities | |||
Hepatocellular carcinoma | 1.02 | 0.21-4.78 | 1.00 |
Diabetes | 0.80 | 0.17-3.58 | 1.00 |
Hypertension | 1.40 | 0.29-7.76 | 0.91 |
Depression | 0.54 | 0.01-6.05 | 1.00 |
Liver disease severity | |||
Cirrhosis | 1.42 | 0.19-9.49 | 0.96 |
FIB-4 | 1.07 | 0.95-1.20 | 0.29 |
FIB-4, ≥ 3.25 | 1.17 | 0.25-6.70 | 1.00 |
Treatment naïve | 1.14 | 0.15-6.77 | 1.00 |
Treatment Regimen | |||
SOF/RBV | REF | REF | REF |
SOF/PEG/RBV | 0.86 | 0.11-3.19 | 1.00 |
Genotype | |||
1 | REF | REF | REF |
2 | 6.25 | 0.26-477.66 | 0.39 |
3 | 1.90 | 0.13-18.36 | 0.86 |
4 | 2.75 | 0.03-228.51 | 0.95 |
Labs | |||
Hemoglobin (g/dL) | 0.61 | 0.40-0.88 | < 0.01 |
(Ref: 13.9-16.3 g/dL) | |||
Platelets (× 103/μL) | 0.99 | 0.98-1.00 | 0.26 |
(Ref: 150-450 × 103/μL) | |||
HCV viral load [log10 (IU/mL)] | 0.90 | 0.38-2.44 | 0.82 |
(Ref: 15-108 IU/mL) | |||
Serum creatinine (mg/dL) | 2.27 | 0.88-8.82 | 0.09 |
(Ref: 0.70-1.40 mg/dL) | |||
eGFR (mL/min per 1.73 m2) | 0.95 | 0.90-0.99 | 0.01 |
Albumin (g/dL) | 0.45 | 0.13-1.32 | 0.15 |
(Ref: 3.5-4.9 g/dL) | |||
ALT (U/L) | 0.99 | 0.97-1.00 | 0.19 |
(Ref: 1-53 U/L) | |||
AST (U/L) | 1.00 | 0.99-1.00 | 0.54 |
(Ref: 1-50 U/L) | |||
INR | 1.27 | 1.12-1.14 | 0.22 |
Total bilirubin (mg/dL) | 2.43 | 1.17-8.65 | < 0.01 |
(Ref: 0.1-1.2 mg/dL) | |||
Alpha fetoprotein (ng/mL) | 0.25 | 0.99-1.11 | 0.15 |
(Ref: 0.0-9.0 ng/mL) |
- Citation: Patel N, Bichoupan K, Ku L, Yalamanchili R, Harty A, Gardenier D, Ng M, Motamed D, Khaitova V, Bach N, Chang C, Grewal P, Bansal M, Agarwal R, Liu L, Im G, Leong J, Kim-Schluger L, Odin J, Ahmad J, Friedman S, Dieterich D, Schiano T, Perumalswami P, Branch A. Hepatic decompensation/serious adverse events in post-liver transplantation recipients on sofosbuvir for recurrent hepatitis C virus. World J Gastroenterol 2016; 22(9): 2844-2854
- URL: https://www.wjgnet.com/1007-9327/full/v22/i9/2844.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i9.2844